- Home
- AVTX vs ANIK Comparison
AVTX vs ANIK Comparison
Compare AVTX & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- ANIK
- Stock Information
- Founded
- AVTX 2011
- ANIK 1983
- Country
- AVTX United States
- ANIK United States
- Employees
- AVTX N/A
- ANIK N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- ANIK Medical/Dental Instruments
- Sector
- AVTX Health Care
- ANIK Health Care
- Exchange
- AVTX Nasdaq
- ANIK Nasdaq
- Market Cap
- AVTX 138.8M
- ANIK 133.1M
- IPO Year
- AVTX 2015
- ANIK 1993
- Fundamental
- Price
- AVTX $10.66
- ANIK $8.62
- Analyst Decision
- AVTX Strong Buy
- ANIK Buy
- Analyst Count
- AVTX 8
- ANIK 1
- Target Price
- AVTX $31.00
- ANIK $15.00
- AVG Volume (30 Days)
- AVTX 209.8K
- ANIK 96.7K
- Earning Date
- AVTX 11-06-2025
- ANIK 10-30-2025
- Dividend Yield
- AVTX N/A
- ANIK N/A
- EPS Growth
- AVTX N/A
- ANIK N/A
- EPS
- AVTX N/A
- ANIK N/A
- Revenue
- AVTX $441,000.00
- ANIK $114,548,000.00
- Revenue This Year
- AVTX N/A
- ANIK N/A
- Revenue Next Year
- AVTX N/A
- ANIK $5.33
- P/E Ratio
- AVTX N/A
- ANIK N/A
- Revenue Growth
- AVTX N/A
- ANIK 16.52
- 52 Week Low
- AVTX $3.39
- ANIK $7.87
- 52 Week High
- AVTX $16.00
- ANIK $26.00
- Technical
- Relative Strength Index (RSI)
- AVTX 61.15
- ANIK 43.26
- Support Level
- AVTX $8.65
- ANIK $8.37
- Resistance Level
- AVTX $12.41
- ANIK $8.89
- Average True Range (ATR)
- AVTX 0.88
- ANIK 0.41
- MACD
- AVTX -0.00
- ANIK -0.00
- Stochastic Oscillator
- AVTX 54.79
- ANIK 19.86
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.